Total Cancer Care Protocol: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer (ORIEN)
The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new clinical trials, new technology, new informatics solutions and "personalized medicine".
Why this Research Matters
This study plans to learn more about how to improve standard cancer care. Cancer is a tough disease to treat because few cancers behave in the same way. Recent research suggests that information stored in your blood, tissues and body fluids can be studied
Who can Participate
Inclusion Criteria: 1. 18 years of age and older 2. Diagnosed with cancer, or may be at risk for cancer 3. Able to understand and sign the TCCP Informed Consent and Research Authorization Form. Spanish-speaking subjects will be consented using the a
Study ID
Protocol Number: 15-1110
More information available at ClinicalTrials.gov: NCT03617939
Meet the Team
Principal Investigator